Equity benchmarks extended losses amid volatility, tracking weak global cues after trade deficit data.
The 30-share BSE Sensex was down 117.83 points at 32,824.04 and the 50-share NSE Nifty fell 44.20 points to 10,142.40.
Shares of Sun Pharmaceutical Industries today fell by over 3 percent after the company reported a 59.19 percent decline in consolidated net profit for the September quarter.
Pharma major Sun Pharmaceutical Industries yesterday reported a 59.19 percent drop in consolidated net profit to Rs 912.12 crore for the September quarter, mainly on account of degrowth in the US sales.
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.
Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of the previous year.
For more information & more gold and silver tips
Call us ✆ – 0731-6642300 or
Visit http://ift.tt/1k8NnLH
Connect with our social media sites
Follow @Epic_Research
The 30-share BSE Sensex was down 117.83 points at 32,824.04 and the 50-share NSE Nifty fell 44.20 points to 10,142.40.
Shares of Sun Pharmaceutical Industries today fell by over 3 percent after the company reported a 59.19 percent decline in consolidated net profit for the September quarter.
Pharma major Sun Pharmaceutical Industries yesterday reported a 59.19 percent drop in consolidated net profit to Rs 912.12 crore for the September quarter, mainly on account of degrowth in the US sales.
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.
Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of the previous year.
For more information & more gold and silver tips
Call us ✆ – 0731-6642300 or
Visit http://ift.tt/1k8NnLH
Connect with our social media sites
Follow @Epic_Research
0 comments:
Post a Comment